BioCryst Pharmaceuticals Inc
Closed
SectorHealthcare
9.66 -3.98
Overview
Share price change
24h
Min
9.59
Max
10.06
Income | 800M 78M |
|---|---|
Sales | 62M 218M |
P/E Sector Avg | 7.603 57.371 |
EPS | 0.3 |
Profit margin | 35.92 |
Employees | 435 |
EBITDA | 799M 99M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +102.98% upside |
Next Earnings | 2 lis 2026 |
|---|
Market Cap | 301M 2.5B |
|---|---|
Previous open | 13.64 |
Previous close | 9.66 |
News Sentiment
By Acuity
55%
45%
284 / 340 Ranking in Healthcare
BioCryst Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
BioCryst Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 20.44 USD 102.98%
High 32 USD
Low 12 USD
Based on 9 Wall Street analysts offering 12 month price targets forBioCryst Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$